Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Redfield

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Journal of Acquired Immune Deficiency Syndromes|September 1, 1993
Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop)D R Lucey, T C VanCott, L D Loomis, et al.
JPMA. the Journal of the Pakistan Medical Association|March 1, 1988
The serological markers of hepatitis A and B in healthy population in northern PakistanI A Malik, L J Legters, M Luqman, et al.
The Journal of Infectious Diseases|October 23, 1997
Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected personsK V Sitz, L D Loomis-Price, S Ratto-Kim, et al.
Lancet (London, England)|December 22, 1984
HTLV-III in symptom-free seronegative personsS Z Salahuddin, J E Groopman, P D Markham, et al.
Lancet (London, England)|September 21, 1985
Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivoS Broder, R Yarchoan, J M Collins, et al.
Journal of the American Academy of Dermatology|November 1, 1985
Severe molluscum contagiosum infection in a patient with human T cell lymphotrophic (HTLV-III) diseaseR R Redfield, W D James, D C Wright, et al.
The Journal of Infectious Diseases|January 7, 1999
Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative responseS Ratto-Kim, K V Sitz, R P Garner, et al.
Journal of Clinical Microbiology|January 1, 1992
Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United StatesR Q Warren, W M Nkya, J F Shao, et al.
JAMA|March 15, 1985
Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDSR R Redfield, P D Markham, S Z Salahuddin, et al.
Journal of Medical Virology|May 1, 1992
Fine specificity of the humoral immune response to HIV-1 GP160 in HIV-1 infected individuals from TanzaniaW M Nkya, R Q Warren, H Wolf, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Journal of Acquired Immune Deficiency Syndromes|September 1, 1993
Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop)D R Lucey, T C VanCott, L D Loomis, et al.
JPMA. the Journal of the Pakistan Medical Association|March 1, 1988
The serological markers of hepatitis A and B in healthy population in northern PakistanI A Malik, L J Legters, M Luqman, et al.
The Journal of Infectious Diseases|October 23, 1997
Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected personsK V Sitz, L D Loomis-Price, S Ratto-Kim, et al.
Lancet (London, England)|December 22, 1984
HTLV-III in symptom-free seronegative personsS Z Salahuddin, J E Groopman, P D Markham, et al.
Lancet (London, England)|September 21, 1985
Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivoS Broder, R Yarchoan, J M Collins, et al.
Journal of the American Academy of Dermatology|November 1, 1985
Severe molluscum contagiosum infection in a patient with human T cell lymphotrophic (HTLV-III) diseaseR R Redfield, W D James, D C Wright, et al.
The Journal of Infectious Diseases|January 7, 1999
Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative responseS Ratto-Kim, K V Sitz, R P Garner, et al.
Journal of Clinical Microbiology|January 1, 1992
Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United StatesR Q Warren, W M Nkya, J F Shao, et al.
JAMA|March 15, 1985
Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDSR R Redfield, P D Markham, S Z Salahuddin, et al.
Journal of Medical Virology|May 1, 1992
Fine specificity of the humoral immune response to HIV-1 GP160 in HIV-1 infected individuals from TanzaniaW M Nkya, R Q Warren, H Wolf, et al.
Pageof 11